BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3010204)

  • 1. Second-look laparotomy in the management of malignant germ cell tumors of the ovary.
    Gershenson DM; Copeland LJ; del Junco G; Edwards CL; Wharton JT; Rutledge FN
    Obstet Gynecol; 1986 Jun; 67(6):789-93. PubMed ID: 3010204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau.
    Germá JR; Izquierdo MA; Seguí MA; Climent MA; Ojeda B; Alonso C
    Gynecol Oncol; 1992 May; 45(2):153-9. PubMed ID: 1375576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary chemotherapy and the role of second-look laparotomy in non-dysgerminomatous germ cell malignancies of the ovary.
    Pippitt CH; Cain JM; Hakes TB; Pierce VK; Lewis JL
    Gynecol Oncol; 1988 Oct; 31(2):268-75. PubMed ID: 2458993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant ovarian germ cell tumors: a review of thirty-six cases.
    Micha JP; Kucera PR; Berman ML; Romansky S; Flamm M; Reynolds J; DiSaia PJ
    Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):842-6. PubMed ID: 2411136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report).
    Slayton RE; Park RC; Silverberg SG; Shingleton H; Creasman WT; Blessing JA
    Cancer; 1985 Jul; 56(2):243-8. PubMed ID: 2988740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.
    Gershenson DM; Morris M; Cangir A; Kavanagh JJ; Stringer CA; Edwards CL; Silva EG; Wharton JT
    J Clin Oncol; 1990 Apr; 8(4):715-20. PubMed ID: 1690272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
    Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
    J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatin.
    Gershenson DM; Kavanagh JJ; Copeland LJ; Del Junco G; Cangir A; Saul PB; Stringer CA; Edwards CL; Wharton JT
    Cancer; 1986 May; 57(9):1731-7. PubMed ID: 2420435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential combination chemotherapy for malignant germ cell tumors of the ovary.
    Germá JR; Piera JM; Barnadas A; Badia J
    Cancer; 1988 Mar; 61(5):913-8. PubMed ID: 2827883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide.
    Gershenson DM; Copeland LJ; Kavanagh JJ; Cangir A; Del Junco G; Saul PB; Stringer CA; Freedman RS; Edwards CL; Wharton JT
    Cancer; 1985 Dec; 56(12):2756-61. PubMed ID: 2996746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases.
    Mitchell PL; Al-Nasiri N; A'Hern R; Fisher C; Horwich A; Pinkerton CR; Shepherd JH; Gallagher C; Slevin M; Harper P; Osborne R; Mansi J; Oliver T; Gore ME
    Cancer; 1999 May; 85(10):2232-44. PubMed ID: 10326703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin, vinblastine and bleomycin in advanced and relapsed germ cell tumours of ovary.
    Kumar L; Bhargawa VL; Kumar S
    Asia Oceania J Obstet Gynaecol; 1993 Jun; 19(2):133-40. PubMed ID: 7691050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
    Tangir J; Zelterman D; Ma W; Schwartz PE
    Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of malignant germ cell tumor of the ovary.
    Aziz MF
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
    Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
    Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovary.
    Taylor MH; Depetrillo AD; Turner AR
    Cancer; 1985 Sep; 56(6):1341-9. PubMed ID: 2411377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current treatment of malignant ovarian germ cell tumors].
    Schwartz PE
    Jugosl Ginekol Perinatol; 1989; 29(3-4):113-8. PubMed ID: 2557491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.